Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
INM

Updated 10/6/2026, 4:26 PM ET.

INM

InMed Pharmaceuticals Inc.

Buy$57,080

ADAR1 Capital Management, LLC

10% owner

and 1 other

42,920 shat $1.33Filed Oct 5, 5:11 PM ETFiling
INM

InMed Pharmaceuticals Inc.

Buy$118,076

ADAR1 Capital Management, LLC

10% owner

and 1 other

91,101 shat $1.30Filed Sep 16, 6:58 PM ETFiling
INM

InMed Pharmaceuticals Inc.

Buy$1,555

ADAR1 Capital Management, LLC

10% owner

and 1 other

1,000 shat $1.56Filed Jul 17, 7:29 PM ETFiling
INM

InMed Pharmaceuticals Inc.

Buy$31,846

Vivo Opportunity, LLC

10% owner

and 3 others

20,546 shat $1.55Filed Jul 16, 9:58 PM ETFiling

Read from public SEC filings. Not financial advice.